


Aims to achieve an attractive level of income combined with capital growth.
| Name | % Net Assets |
|---|---|
| HSBC | 5.1% |
| British American Tobacco | 4.4% |
| Centrica | 4.3% |
| Royal Dutch Shell 'B' | 4.1% |
| BP | 3.5% |
| Vodafone | 3.5% |
| Aviva | 3.5% |
| GlaxoSmithKline | 3.5% |
| National Grid | 3.5% |
| AstraZeneca | 3.3% |
| Key | % Net Assets |
|---|---|
| 5.1% | |
| 4.4% | |
| 4.3% | |
| 4.1% | |
| 82.1% |
| Date | 14-Sep-2018 |
|---|---|
| NAV | 1,444.91p |
| Currency | GBP |
| Change | 4.98p |
| % | 0.35% |
| YTD change | 1,444.91p |
| YTD % | n/a |
| Fund Inception | n/a |
|---|---|
| Fund Manager | Pan European Equities Team |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research